Thorne Healthtech, Inc.
DelistedCIK 1844280fmd_07VZ1X8AD0WGRAZN46XXPNV1R9Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2023, 12 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Total revenues | 138 | 184 | 229 |
| Cost of revenue | 74 | 88 | 114 |
| Gross profit | 65 | 96 | 115 |
| Research and development | 4 | 6 | 7 |
| Selling, general and administrative | 48 | 56 | 76 |
| Operating income | 1 | 10 | 5 |
| Other non-operating income (expense) | (3) | 1 | 2 |
| Income before taxes | (2) | 11 | 8 |
| Income tax expense | 0 | 0 | (7) |
| Net income from continuing operations | (2) | 11 | 15 |
| Net income | (3) | 7 | 16 |
| Net income to common shareholders | (3) | 4 | 16 |